Skip to main content

Table 5 Lead-ECs for the centres in Austria, France and Switzerland

From: High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08

Country

Lead Ethical committee

Austria

Ethikkommission der Medizinischen Universität Innsbruck (AM4161b_LEK)

France

Comité de Protection des Personnes EST I (2011–52)

Switzerland

Ethikkommission Ostschweiz (EKSG 10/029)